I think that Ryan’s 2022 is more than a pass as he started selling the Rox story and to be fair January is a quiet time in most places. However, the first announcement for the year being a grab for free shares by management is appallingly in bad taste. You don’t need to be a rocket scientist to work out why they have gone for (FREE) Performance Rights rather than (PAID FOR) options.
The rejection of the Performance Rights to the old Board Members is a no brainer. As for Ryan, he has a couple of weeks to sell to us why we should vote for him getting the PRs.
Fortunately, RXL seems to have a reasonably rational shareholder base where voting will not automatically favour management. I owned shares in another company where super outrageous Performance Rights were issued to a management team that has not delivered consistently. If their CEO passed wind into a jar the diehard shareholders would be insisting that it was perfume.
The upcoming vote is a good opportunity to keep RXL Management honest and to create respect for retail shareholders.
- Forums
- ASX - By Stock
- RXL
- Rox in 2023
RXL
rox resources limited
Add to My Watchlist
1.75%
!
29.0¢

Rox in 2023, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $212.4M |
Open | High | Low | Value | Volume |
28.5¢ | 29.5¢ | 28.5¢ | $783.8K | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 87999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.285 |
1 | 85506 | 0.280 |
2 | 52000 | 0.275 |
12 | 315190 | 0.270 |
3 | 243500 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 27999 | 1 |
0.295 | 106291 | 2 |
0.300 | 128300 | 4 |
0.305 | 144436 | 3 |
0.310 | 60003 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online